BERNARD ZOVIGHIAN
CEO
EDWARDS LIFESCIENCES CORP.
WHY: Took over the top spot at OC’s most valuable medical device maker from Mike Mussallem, the only CEO the heart valve company has known since going public in 2000, two years ago.
IN THE NEWS: Recently made major changes including selling the company’s slowest growing unit to Becton, Dickinson and Co. for $4.2B and spending $1.5B to acquire three heart-focused companies, reflecting the company’s shift to a purely structural heart company.
NOTABLE: Previously headed smallest but fastest-growing unit, Transcatheter Mitral and Tricuspid Therapies, which doubled sales to $86M in 2021 and another nearly 50% to $116M in 2022.
QUOTABLE: “If you want to be an innovator, you need to be ready to fail—you need to be ready to pivot back.”
